Bio-Gene Technology Limited

ASX (AUD): Bio-Gene Technology Limited (BGT)

Last Price

0.052

Today's Change

-0.001 (1.88%)

Day's Change

0.05 - 0.065

Trading Volume

4,844,796

Profile
BGT

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Timothy Owen Grogan B.Sc., LLB Mr. Timothy Owen Grogan B.Sc., LLB

Full Time Employees:  0 0

IPO Date:  2017-11-28 2017-11-28

CIK: 

ISIN:  AU000000BGT8 AU000000BGT8

CUSIP:  Q1506Q101 Q1506Q101

Beta:  0.70 0.70

Last Dividend:  0.00 0.00

Dcf Diff:  0.04 0.04

Dcf:  0.01 0.01

Description

Bio-Gene Technology Limited, an agtech development company, engages in developing and commercializing insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. Its lead products include Flavocide, a beta-triketone insecticide product; and Qcide, a natural oil extracted from a cultivar of eucalyptus cloeziana. The company has a research collaboration agreement with James Cook University for the development of a tissue culture system to support the expansion of tree plantations and scale-up of future Qcide oil production. It also has research collaborations with BASF, Grains Research and Development Corporation, and Queensland Department of Agriculture and Fisheries for assessing activity against grain storage pests. Bio-Gene Technology Limited was incorporated in 1995 and is based in Melbourne, Australia.

Address

456 Lonsdale Street,
Melbourne, VIC 3000, AU

61 3 9068 1062

http://www.bio-gene.com.au

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment